Name:  [**Known lastname 16484**],[**Known firstname 540**]                  Unit No:   [**Numeric Identifier 16485**]  Admission Date:  [**2142-6-11**]              Discharge Date:   [**2142-6-19**]  Date of Birth:  [**2073-7-25**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Lipitor / Zocor  Attending:[**First Name3 (LF) 1999**] Addendum: see discharge summary  Chief Complaint: The patient is a 69-year-old woman who had undergone an x-ray for shoulder pain that had disclosed bilateral lung abnormalities.
A CT scan was performed and confirmed a solid nodule in the superior segment of her left lower lobe highly suspicious for malignancy as well as a bulla in the right lower lobe with a thickened cyst wall also concerning for malignancy.
A PET scan was performed subsequent to the CT scan.
She also underwent an MRI scan on [**2142-5-24**], that was negative for metastatic disease.
In addition, a PFT was performed in [**Month (only) **] [**2141**] disclosing FEV1 of 133% of predicted and a diffusion capacity of 82% of predicted.
The mediastinoscopy was negative for carcinoma.
Major Surgical or Invasive Procedure: [**2142-6-11**]: Left VATS converted to left anterior thoracotomy, resection of superior segment of the left lower lobe, mediastinal lymph node dissection   History of Present Illness: The patient is a 69-year-old woman who had undergone an x-ray for shoulder pain that had disclosed bilateral lung abnormalities.
A CT scan was performed and confirmed a solid nodule in the superior segment of her left lower lobe highly suspicious for malignancy as well as a bulla in the right lower lobe with a thickened cyst wall also concerning for malignancy.
A PET scan was performed subsequent to the CT scan.
She also underwent an MRI scan on [**2142-5-24**], that was negative for metastatic disease.
In addition, a PFT was performed in [**Month (only) **] [**2141**] disclosing FEV1 of 133% of predicted and a diffusion capacity of 82% of predicted.
The mediastinoscopy was negative for carcinoma.
Osteoarthritis 11.
Clear to auscultation bilaterally.
Pertinent Results: [**2142-6-19**] WBC-8.0 RBC-3.15* Hgb-9.2* Hct-27.9* Plt Ct-352# [**2142-6-16**] WBC-8.3 RBC-2.74* Hgb-8.1* Hct-24.4* Plt Ct-230 [**2142-6-11**] WBC-13.2* RBC-3.97* Hgb-12.0 Hct-36.1 Plt Ct-365 [**2142-6-16**] Glucose-91 UreaN-27* Creat-1.1 Na-140 K-4.1 Cl-106 HCO3-25 [**2142-6-11**] Glucose-172* UreaN-37* Creat-1.5* Na-137 K-4.0 Cl-108 HCO3-15*  [**2142-6-19**] INR 2.8    [**2142-6-18**]  INR 3.8  [**2142-6-17**] INR 1.9 [**2142-6-16**] INR 1.3  CXR [**2142-6-15**] IMPRESSION: 1.
Left ventricular wall thicknesses are normal.
She developed postoperative Atrial Fibrillation with a rapid ventricular rate soon afterwards and her blood pressure was initially 80/40, leading to a transfer to the intensive care unit.
By [**6-14**], the patient had rate stabilized at around 110-120 and her pressures was around 109/47.
On [**6-18**] her INR was 3.8 the coumadin was held and a repeat INR on [**6-19**] was 2.8.
Outpatient Lab Work [**Hospital1 8**]-[**Location (un) **]--please check INR twice a week.
Goal INR is between 2 and 3.
Outpatient Lab Work [**Hospital1 8**]-[**Location (un) **]--please check INR twice a week.
Goal INR is between 2.0-2.5  Please call PCP with results.
Coumadin 1 mg Tablet Sig: One (1) Tablet PO as directed to maintain INR 2.0-2.5.
Coumadin for atrial fibrillation: INR Goal 2.0-2.5 Call Dr. [**Last Name (STitle) **] office for coumadin dosing.
Blood Draw on [**6-20**] at the [**Hospital1 8**] [**Location (un) **] coumadin clinic.
Follow-up with Dr. [**Last Name (STitle) **] on [**2142-7-3**] at 3:30pm [**Hospital Ward Name **] Clinical Center Report to the 4th Radiology Department for a Chest X-Ray 45 minutes before your appointment.
Also please call [**Hospital1 8**] [**Location (un) **] at [**Telephone/Fax (1) 16486**] for an appointment on Wednesday to have your INR checked and coumadin assessed.
